BFC Planning’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.1K Hold
150
– – ﹤0.01% 2329
2026
Q2
$10.3K Buy
+150
New +$10K ﹤0.01% 2356
2024
Q4
– Sell
-56
Closed -$3.75K – 2697
2024
Q3
$3.75K Buy
+56
New +$3.8K ﹤0.01% 2105

Other funds holding UTMD

BFC Planning's UTMD Position: Q3 2026 in Review

BFC Planning held its Utah Medical Products (UTMD) position steady in Q3 2026 at 150 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

BFC Planning first reported a position in UTMD in Q3 2024 and has held it in 3 quarters since. 97 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • BFC Planning held 150 shares of Utah Medical Products worth $11.1K as of Q3 2026.
  • BFC Planning left its Utah Medical Products share count unchanged in Q3 2026.
  • Utah Medical Products made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2329 holding.
  • BFC Planning first reported a position in Utah Medical Products in Q3 2024 and has held it in 3 quarters since.
  • 97 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.